文献速递免疫规划卫生政策与健康促进

英格兰儿童普遍水痘疫苗接种的影响与成本效果建模

Modelling the impact and cost effectiveness of universal varicella vaccination in England.
PubMed 文献 · Vaccine · 2025-02-12

该研究采用年龄结构动态传播模型与卫生经济学决策树,评估英格兰儿童水痘疫苗接种规划的影响与成本效果,纳入水痘与带状疱疹最新流行病学数据及外源性加强效应。结果显示两剂次接种可显著降低水痘发病率并可能接近消除,但模型预测带状疱疹发病率会因自然加强减少而暂时上升,该效应部分被现有带状疱疹疫苗规划抵消且远小于既往估计。所有模拟策略在常规阈值下均具成本效果,常规接种情景最具经济优势,疫苗价格与水痘治疗费用是成本效果的主要驱动因素。

要点

  • 两剂次水痘疫苗接种可显著降低水痘发病率,高覆盖率维持下可能接近消除。
  • 模型预测带状疱疹发病率会因自然加强减少而暂时上升,但效应远小于既往估计且部分被现有带状疱疹疫苗规划抵消。
  • 所有模拟接种策略在常规阈值下均具成本效果,常规接种情景最具经济优势。

核心结论

  • 研究支持在英格兰引入儿童水痘疫苗接种规划,该规划可带来显著健康获益且极可能具有成本效果。

研究设计与样本

  • 采用年龄结构动态传播模型与卫生经济学决策树,纳入水痘和带状疱疹最新流行病学数据(包括外源性加强对带状疱疹发病率的影响),模拟包括常规接种和补种规划在内的多种疫苗接种策略,从NHS视角评估疫苗成本效果。

主要发现

  • 两剂次水痘疫苗接种规划可显著降低水痘发病率,若维持高覆盖率可能接近消除。
  • 模型预测带状疱疹发病率会因水痘暴露减少导致自然加强减弱而暂时上升,该效应部分被现有带状疱疹疫苗规划抵消,且远小于既往估计。
  • 成本效果分析显示所有模拟的疫苗接种策略在常规阈值下均具成本效果,其中常规接种情景最具经济优势。
  • 敏感性分析表明疫苗价格和水痘治疗费用是成本效果的主要驱动因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Two distinct diseases are attributable to the varicella zoster virus, varicella (chickenpox) and zoster (shingles). This study assesses the impact and cost-effectiveness of a childhood varicella vaccination program in England. METHODS: We use an age-structured dynamic transmission model and a health economic decision tree. The model incorporates recent data on varicella and zoster epidemiology, including the effects of exogenous boosting on zoster incidence. By simulating various vaccination strategies, including routine and catch-up programs, the study evaluates the potential reduction in varicella and zoster cases due to vaccination and the associated vaccine cost-effectiveness (from the NHS perspective). RESULTS: We find that a two-dose varicella vaccination program could significantly reduce varicella incidence, potentially achieving near-elimination if high coverage rates are maintained. However, the model also predicts a temporary increase in zoster incidence due to reduced natural boosting from varicella exposure; this is partly mitigated by the current zoster vaccination program and the effect is much less substantial than previously estimated. Cost-effectiveness analyses reveal that all vaccination strategies modelled are cost-effective at typical thresholds, with the routine vaccination scenario being the most economically advantageous. Sensitivity analyses demonstrate that vaccine price and varicella treatment costs are the primary drivers of cost-effectiveness. CONCLUSION: The study supports the introduction of a childhood varicella vaccination program in England, which offers substantial health benefits and is highly likely to be cost-effective.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Adams L, Karachaliou Prasinou A, Trotter C, et al. Modelling the impact and cost effectiveness of universal varicella vaccination in England. Vaccine. 2025. PMID: 39946866. doi:10.1016/j.vaccine.2025.126831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。